You are here

Multi Injection Vial Anti-contamination cap (MIVA-Cap)

Award Information
Agency: Department of Defense
Branch: Office for Chemical and Biological Defense
Contract: W911SR-22-P-0002
Agency Tracking Number: C212-004-0074
Amount: $167,470.02
Phase: Phase I
Program: SBIR
Solicitation Topic Code: CBD212-004
Solicitation Number: 21.2
Solicitation Year: 2021
Award Year: 2022
Award Start Date (Proposal Award Date): 2022-02-14
Award End Date (Contract End Date): 2022-08-13
Small Business Information
1225 S Shamrock Ave
Monrovia, CA 91016-4244
United States
DUNS: 168312028
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Ricky Whitener
 (626) 381-9974
Business Contact
 Naresh Menon
Phone: (626) 381-9974
Research Institution

To meet CBD’s need for a multi-dose formulation of scopolamine hydrobromide trihydrite ChromoLogic proposes to develop a vial add-on containing a self-decontamination cap with a self-healing material to eliminate evaporation and contamination risks through needle punctures in the septum. CL will also perform forced degradation and stability tests with a panel of preservatives to select optimal preservative/concentration and achieve target shelf-life. Overall, CL plans to work with the CBD to ensure this product is an amendment to their already existing FDA process for approval of their single-dose formulation.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government